10x Genomics valuation

TXG · NASDAQ · USD

Compare 10x Genomics
$56.30Change from previous close: +2.38%Absolute change: +$1.31

Close · November 17, 2026

Valuation

The average price target of 14 analysts is $68.14.

Data as of November 15, 2026

10x Genomics compared with similar companies

10x Genomics's Price/book: 9.13, +81% against the median of a group of 11 similar companies (5.04).

10x Genomics's metrics compared with similar companies
Metric10x GenomicsMedian25th–75th percentileBand
Price/book9.135.042.90 – 7.18High
Price/sales12.44.053.08 – 7.03High
Gross margin72.0%68.0%64.3% – 70.6%High
Operating margin-10.6%19.2%15.2% – 22.0%Low
Net margin-10.8%13.4%10.0% – 14.6%Low
ROE-8.3%11.6%10.0% – 18.0%Low
Debt/equity0.090.550.21 – 0.63Low

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Other metrics

Valuation multiples

Market cap
$7.65B
Enterprise value
$7.15B
P/E (trailing 12 months)
-142.2
Forward P/E
671.4
EV/EBITDA
-269.9
EV/revenue
11.6

Profitability and growth

ROA
-3.9%
ROIC
-5.8%
Revenue growth (year over year)
1.1%
Earnings growth (year over year)
-150.2%

Financial health

Total cash
$575.68M
Total debt
$75.79M
Current ratio
5.12
Quick ratio
4.52
Altman Z-Score
9.25
Piotroski F-Score
4.00

Dividends

Dividend yield
0.0%

Analysts and estimates

Average price target
$68.14
Median price target
$65.00
High price target
$100.00
Low price target
$50.00
Analysts with a price target
14
Consensus
Buy
Forward EPS
$0.09
EPS estimate, current year
$0.06

Shares and trading

Beta
2.03
Average volume
3.37M
Shares outstanding
121.46M
Float
119.44M
Institutional ownership
115.6%
Insider ownership
1.8%
Short interest (% of float)
13.9%
Short ratio (days)
3.13